Mpox (Monkeypox)

The JYNNEOS vaccine has been approved by the U.S. FDA for protection against the mpox virus for individuals who have been exposed to mpox and for those who are more likely to get mpox. Mpox vaccination for the general public is currently not recommended at this time. 

Since May, 2022, clusters of mpox (monkeypox) cases have been reported in several countries that don’t normally have monkeypox. Mpox is largely spread through close physical contact.  Many mpox cases in this outbreak are among men who have sex with men. But any person, regardless of gender identity or sexual orientation, can acquire and spread mpox. 

Information on U.S. Mpox Outbreak 

Maryland mpox case data and resources

World Health Organization on mpox name change

Mpox infections are typically not severe; symptoms are usually similar to the flu with a rash and resolve within 2-4 weeks. More severe infections or infections in high-risk individuals may be treated with antiviral medicines.

While COVID-19 passed easily from person to person, mpox does not spread as easily between people. Mpox transmission typically requires skin-to-skin contact, direct contact with body fluids, or prolonged face-to-face contact; this includes sexual contact. It can also be spread by touching items like towels or sheets that touched an infectious rash or body fluids.

To prevent mpox:

• Avoid close, skin to skin contact with the mpox rash.
  • Do not touch the rash or scabs of person with mpox.
  • Do not kiss, hug, cuddle or have sex with someone with mpox.
  • Do not share eating utensils or cups.
• Do not handle or touch the bedding, towels, or clothing of a sick person.
• Wash your hands often with soap and water or use an alcohol-based hand sanitizer, especially after contact with sick people.
• Social Gatherings, Safer Sex, and Mpox

If you think you have been exposed to mpox or may have mpox, talk with your healthcare provider as soon as possible.